This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
WHO report. Global tuberculosis control: surveillance, planning, financing. Geneva: Switzerland, 2007.WHO reportGlobal tuberculosis control: surveillance, planning, financingGenevaSwitzerland2007Search in Google Scholar
Ministry of Public Health, Thailand. National Tuberculosis Control Program Guidelines. Bangkok: Bureau of Tuberculosis, Ministry of Public Health, Thailand; 2013.Ministry of Public HealthThailand. National Tuberculosis Control Program GuidelinesBangkokBureau of Tuberculosis, Ministry of Public HealthThailand2013Search in Google Scholar
Olran P, Auchara T, Usa T, editors. Vaccines: 9th International Congress of Tropical Pediatrics. Bangkok, Thailand, October 18–20, 2011. Bangkok: Noppachai Printing; 2011.OlranPAucharaTUsaTVaccines: 9th International Congress of Tropical PediatricsBangkok, ThailandOctober 18–202011BangkokNoppachai Printing2011Search in Google Scholar
WHO Expert Committee on Biological Standardization (36th Report). World Health Organization Technical Report Series 745. Geneva: WHO; 1987.WHO Expert Committee on Biological Standardization (36th Report)World Health Organization Technical Report Series745GenevaWHO1987Search in Google Scholar
Seki M, Honda I, Fujita I, Yano I, Yamamoto S, Koyama A. Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette–Guérin (BCG) Tokyo 172: A comparative study of BCG vaccine substrains. Vaccine. 2009; 27:1710-6.1920044910.1016/j.vaccine.2009.01.034SekiMHondaIFujitaIYanoIYamamotoSKoyamaA.Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette–Guérin (BCG) Tokyo 172: A comparative study of BCG vaccine substrainsVaccine.20092717106Search in Google Scholar
Bedwell J, Kairo SK, Behr MA, Bygraves JA. Identification of substrains of BCG vaccine using multiplex PCR. Vaccine. 2001; 19:2146-51.10.1016/S0264-410X(00)00369-811228387BedwellJKairoSKBehrMABygravesJA.Identification of substrains of BCG vaccine using multiplex, PCRVaccine.200119214651Open DOISearch in Google Scholar
Shibayama K, Mochida K, Yagi T, Mori S, Arakawa Y, Yamamoto S. Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time PCR. Biologicals. 2007; 35: 139-43.1707450910.1016/j.biologicals.2006.07.005ShibayamaKMochidaKYagiTMoriSArakawaYYamamotoS.Quantification of two variant strains contained in freeze-dried Japanese BCG vaccine preparation by real-time, PCRBiologicals.2007351394317074509Search in Google Scholar
Naka T, Maeda S, Niki M, Ohara N, Yamamoto S, Yano I, et al. Lipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette–Guérin Tokyo 172 substrain. J Biol Chem. 2011; 286:44153-61.2203039510.1074/jbc.M111.310037NakaTMaedaSNikiMOharaNYamamotoSYanoILipid phenotype of two distinct subpopulations of Mycobacterium bovis Bacillus Calmette–Guérin Tokyo 172 substrainJ Biol Chem.20112864415361324354422030395Search in Google Scholar
Guenin-Mace L, Simeone R, Demangel C. Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression. Transbound Emerg Dis. 2009; 56:255-68.10.1111/j.1865-1682.2009.01072.x19486312Guenin-MaceLSimeoneRDemangelC.Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppressionTransbound Emerg Dis.2009562556819486312Open DOISearch in Google Scholar
Camacho LR, Constant P, Raynaud C, Laneelle MA, Triccas JA, Gicquel B, et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem. 2001; 276:19845-54.1127911410.1074/jbc.M100662200CamachoLRConstantPRaynaudCLaneelleMATriccasJAGicquelBAnalysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrierJ Biol Chem.2001276198455411279114Search in Google Scholar
Wada T, Maruyama F, Iwamoto T, Maeda S, Yamamoto T, Nakagawa I, et al. Deep sequencing analysis of the heterogeneity of seed and commercial lots of the bacillus Calmette-Guérin (BCG) tuberculosis vaccine substrain Tokyo-172. Sci Rep. 2015; 5:17827. 10.1038/srep17827.26635118WadaTMaruyamaFIwamotoTMaedaSYamamotoTNakagawaIDeep sequencing analysis of the heterogeneity of seed and commercial lots of the bacillus Calmette-Guérin (BCG) tuberculosis vaccine substrain Tokyo-172Sci Rep.201551782710.1038/srep17827466946726635118Open DOISearch in Google Scholar
Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P, et al. Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A. 2007; 104:5596-601.1737219410.1073/pnas.0700869104BroschRGordonSVGarnierTEiglmeierKFriguiWValentiPGenome plasticity of BCG and impact on vaccine efficacyProc Natl Acad Sci U S A.20071045596601183851817372194Search in Google Scholar
Ho MM, Markey K, Rigsby P, Hockley J, Corbel MJ.Report of an international collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains. Vaccine. 2011; 29:512-8.2105549610.1016/j.vaccine.2010.10.066HoMMMarkeyKRigsbyPHockleyJCorbelMJ.Report of an international collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strainsVaccine.201129512821055496Search in Google Scholar
Dagg B, Hockley J, Rigsby P, Ho MM. The establishment of sub-strain specific WHO reference reagents for BCG vaccine. Vaccine. 2014; 32:6390-5.10.1016/j.vaccine.2014.09.06525312272DaggBHockleyJRigsbyPHoMM.The establishment of sub-strain specific WHO reference reagents for BCG vaccineVaccine.20143263905422683825312272Open DOISearch in Google Scholar
Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ. 1990; 68:93-108.2189588MilstienJBGibsonJJ.Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safetyBull World Health Organ.19906893108Search in Google Scholar
Frothingham R, Meeker-O’Connell WA. Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology. 1998; 144:1189-96.961179310.1099/00221287-144-5-1189FrothinghamRMeeker-O’ConnellWA.Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeatsMicrobiology.1998144118996Search in Google Scholar
van Belkum A, Scherer S, van Alphen L, Verbrugh H. Short-sequence DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev. 1998; 62:275-93.9618442van BelkumASchererSvan AlphenLVerbrughH.Short-sequence DNA repeats in prokaryotic genomesMicrobiol Mol Biol Rev.1998622759310.1128/MMBR.62.2.275-293.1998Search in Google Scholar
Palucci I, Camassa S, Cascioferro A, Sali M, Anoosheh S, Zumbo A, et al. PE_PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2. PLoS One. 2016; 11:e0150800. 10.1371/journal.pone.0150800.26978522PalucciICamassaSCascioferroASaliMAnooshehSZumboAPE_PGRS33 contributes to Mycobacterium tuberculosis entry in macrophages through interaction with TLR2PLoS One.201611e015080010.1371/journal.pone.0150800Open DOISearch in Google Scholar
Meena LS. An overview to understand the role of PE_PGRS family proteins in Mycobacterium tuberculosis H37Rv and their potential as new drug targets. Biotechnol Appl Biochem. 2015; 62:145-53.10.1002/bab.126624975480MeenaLS.An overview to understand the role of PE_PGRS family proteins in Mycobacterium tuberculosis H37Rv and their potential as new drug targetsBiotechnol Appl Biochem.20156214553Open DOISearch in Google Scholar
Rodriguez-Alvarez M, Palomec-Nava ID, Mendoza- Hernandez G, Lopez-Vidal Y. The secretome of a recombinant BCG substrain reveals differences in hypothetical proteins. Vaccine. 2010; 28:3997-4001.2015379710.1016/j.vaccine.2010.01.064Rodriguez-AlvarezMPalomec-NavaIDMendoza- HernandezGLopez-VidalY.The secretome of a recombinant BCG substrain reveals differences in hypothetical proteinsVaccine.20102839974001Search in Google Scholar
Gheorghiu M, Lagrange PH. Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris). 1983; 134:125-47.GheorghiuMLagrangePH.Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strainsAnn Immunol (Paris).19831341254710.1016/S0769-2625(83)80157-3Search in Google Scholar
Honda I, Seki M, Ikeda N, Yamamoto S, Yano I, Koyama A, et al. Identification of two subpopulations of Bacillus Calmette-Guérin (BCG) Tokyo172 substrain with different RD16 regions. Vaccine. 2006; 24: 4969-74.1662119710.1016/j.vaccine.2006.03.055HondaISekiMIkedaNYamamotoSYanoIKoyamaAIdentification of two subpopulations of Bacillus Calmette-Guérin (BCG) Tokyo172 substrain with different RD16 regionsVaccine.20062449697416621197Search in Google Scholar
Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature. 2004; 431:84-7.1534333610.1038/nature02837ReedMBDomenechPMancaCSuHBarczakAKKreiswirthBNA glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune responseNature.200443184715343336Search in Google Scholar
Seki M, Sato A, Honda I, Yamazaki T, Yano I, Koyama A, et al. Modified multiplex PCR for identification of Bacillus Calmette–Guérin substrain Tokyo among clinical isolates. Vaccine. 2005; 23:3099-102.10.1016/j.vaccine.2004.12.01615837207SekiMSatoAHondaIYamazakiTYanoIKoyamaAModified multiplex PCR for identification of Bacillus Calmette–Guérin substrain Tokyo among clinical isolatesVaccine.200523309910215837207Open DOISearch in Google Scholar
